For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Automated Method Development of Oligonucleotide in Tissues Using Clarity OTX 96-Well Plate and High Resolution Mass Spectrometry (TN-0097)
As synthetic oligonucleotide (oligo) therapeutics move through the drug-development path, there has been an increasing need for TK and PK/PD studies in drug discovery and development. Because of the specificity, sensitivity, and shorter method development time which they afford, LC/MS/MS methods are preferred over ligand binding assays or ELISA. However, isolation of the oligonucleotide is required prior to analysis via LC/MS/MS; the clean and efficient extraction of synthetic oligonucleotides often proves challenging during method development (MD) due to low sample concentration, analyte recovery, and the possible co-extraction of matrix interferences.

Automated Method Development of Oligonucleotide in Tissues Using Clarity OTX 96-Well Plate and High Resolution Mass Spectrometry (TN-0097)

As synthetic oligonucleotide (oligo) therapeutics move through the drug-development path, there has been an increasing need for TK and PK/PD studies in drug discovery and development. Because of the specificity, sensitivity, and shorter method development time which they afford, LC/MS/MS methods are preferred over ligand binding assays or ELISA. However, isolation of the oligonucleotide is required prior to analysis via LC/MS/MS; the clean and efficient extraction of synthetic oligonucleotides often proves challenging during method development (MD) due to low sample concentration, analyte recovery, and the possible co-extraction of matrix interferences.
Document Type:
Technical Notes
Separation Modes:
Reversed Phase, Solid Phase Extraction
Phases: